6 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 30622252 | ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks. | 2019 Jan 8 | 1 |
2 | 30104007 | Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA status. | 2018 | 1 |
3 | 24457564 | The effect of germ-line BRCA mutations on response to chemotherapy and outcome of recurrent ovarian cancer. | 2014 Mar | 1 |
4 | 23548269 | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | 2013 Jun 15 | 1 |
5 | 21855118 | Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers. | 2011 Nov | 5 |
6 | 22101337 | Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent. | 2011 Dec 1 | 1 |